Clarifying clinically treatment-naive status for osteoporosis patients

Patients requiring bone anabolic therapy with romosozumab should be treatment naïve per recent studies. Provincial formularies' interpretation of "treatment naïve" has been quite variable. A scientifically valid definition of "clinically treatment naïve" has been explored.

Link to Article:

https://link.springer.com/article/10.1007/s00198-026-07864-3